Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2020-03-12 2019-12-19
Drug Identification Number 02393603 02393603
Brand name ACT NABILONE ACT NABILONE
Common or Proper name NABILONE 1MG CAPSULES NABILONE 1MG CAPSULES
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients NABILONE NABILONE
Strength(s) 1MG 1MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 50 50
ATC code A04AD A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-10-01
Actual start date 2019-12-18
Estimated end date Unknown
Actual end date 2019-10-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Item is discontinued, transitioned to the TEVA DIN Item is to be discontinued
Health Canada comments